STAT6 and neoplasm: To test this hypothesis, we subjected WT and STAT6−/− mice to an AOM/DSS regimen and analyzed the CAC progression at Day 20, Day 40 (early stages), and Day 68 (late stage of tumor development, where adenoma-like lesions are observed) as an approximation of different stages of tumor progression (Figure 1A).